Education
About Us
Working with TipRanks
Follow Us
Edap Tms S.A. (EDAP)
NASDAQ:EDAP
EDAP Stock Chart & Stats
$2.94
-$0.15(-5.88%)
At close: 4:00 PM EST
$2.94
-$0.15(-5.88%)
Day’s Range― - ―
52-Week Range$1.21 - $3.05
Previous CloseN/A
Volume29.75K
Average Volume (3M)61.70K
Market Cap
$109.93M
Enterprise Value$53.17M
Total Cash (Recent Filing)$10.57M
Total Debt (Recent Filing)$7.55M
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Apr 01, 2026EPS Estimate
-0.14Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding37,392,086
10 Day Avg. Volume79,633
30 Day Avg. Volume61,700
Financial Highlights & Ratios
PEG Ratio0.40
Price to Book (P/B)1.95
Price to Sales (P/S)1.24
P/FCF Ratio-4.50
Enterprise Value/Market Cap0.48
Enterprise Value/Revenue0.83
Enterprise Value/Gross Profit1.93
Enterprise Value/Ebitda-2.99
Forecast
1Y Price Target
$14.00Price Target Upside376.19% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe company reported 3Q25 total revenues of €13.9M, above the consensus estimate of €12.9M.
Market IntegrationManagement noted that their HIFU platform is now integrated into 60% of the leading US academic urology centers.
Product DemandEDAP's core HIFU business is benefiting from increasing demand for their Focal One system for early-stage prostate cancer.
Bears Say
Business Segment DeclineThe non-core ESWL business is expected to decline by 20% - 25%.
EDAP TMS News
EDAP FAQ
What was Edap Tms S.A.’s price range in the past 12 months?
Edap Tms S.A. lowest stock price was $1.21 and its highest was $3.05 in the past 12 months.
What is Edap Tms S.A.’s market cap?
Edap Tms S.A.’s market cap is $109.93M.
When is Edap Tms S.A.’s upcoming earnings report date?
Edap Tms S.A.’s upcoming earnings report date is Apr 01, 2026 which is in 101 days.
How were Edap Tms S.A.’s earnings last quarter?
Edap Tms S.A. released its earnings results on Nov 06, 2025. The company reported -$0.152 earnings per share for the quarter, beating the consensus estimate of -$0.254 by $0.102.
Is Edap Tms S.A. overvalued?
According to Wall Street analysts Edap Tms S.A.’s price is currently Undervalued.
Does Edap Tms S.A. pay dividends?
Edap Tms S.A. does not currently pay dividends.
What is Edap Tms S.A.’s EPS estimate?
Edap Tms S.A.’s EPS estimate is -0.14.
How many shares outstanding does Edap Tms S.A. have?
Edap Tms S.A. has 37,392,086 shares outstanding.
What happened to Edap Tms S.A.’s price movement after its last earnings report?
Edap Tms S.A. reported an EPS of -$0.152 in its last earnings report, beating expectations of -$0.254. Following the earnings report the stock price went down -4.327%.
Which hedge fund is a major shareholder of Edap Tms S.A.?
Currently, no hedge funds are holding shares in EDAP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
EDAP TMS Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$14.00 (376.19% Upside)
$14.00 (376.19% Upside)
Hedge Fund Trend
Decreased
By 115.0K Shares
Last Quarter.
Last Quarter.
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.54%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-8.90%
Trailing 12-Months
Company Description
Edap Tms S.A.
EDAP TMS (EDAP) is a medical technology company specializing in the development and commercialization of innovative therapeutic solutions for urological conditions. The company operates primarily in the healthcare sector, focusing on minimally invasive treatments for prostate cancer and other urological diseases. EDAP's core products include the Ablatherm® high-intensity focused ultrasound (HIFU) device, which offers non-invasive treatment options, and its range of lithotripsy equipment for kidney stone removal.
EDAP Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in revenue growth and clinical advancements in the HIFU segment, alongside increased placements and recognition in the industry. However, challenges remain with decreased performance in noncore areas, continued operating losses, and tariff impacts affecting financials.View all EDAP earnings summariesEDAP Stock 12 Month Forecast
Average Price Target
$14.00
▲(376.19% Upside)